Different and long term chemotherapy treatments or nutritional support require a long term venous access in a cancer patient. Since 1982, the increasingly frequent use of TIVADs has reduced the burden ...
Totally implantable vascular access device (TIVAD)-related complications interfere in the anticancer treatment and increase medical expenses. We examined whether the implantation side of central line ...
A totally implantable venous access device (TIVAD) is necessary for cancer patients who require long-term intravenous chemotherapy. A research group in China investigated which factors reduced the ...
In 102 patients placement of TIVAD via the cephalic vein cutdown approach was initially attempted, 87 patients underwent successful insertion while 15 required conversion to a percutaneous approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results